Uncategorized
Speaker delivers DRCR.net update at Angiogenesis meeting
MIAMI — Harry W. Flynn Jr., MD, discussed the newly published and continuing trials of the Diabetic Retinopathy Clinical Research Network at Angiogenesis, Exudation, and Degeneration 2016.Protocol S, which was recently published, showed that intravitreal Lucentis (ranibizumab, Genentech) was not inferior to panretinal photocoagulation for diabetic macular edema and resulted in better visual acuity over 2 years. The ranibizumab group had a higher chance of a 10-letter score improvement or better, while the PRP group had a higher chance of visual acuity worsening by 10 letters or more, as well (Read more...)